These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36697313)

  • 21. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
    Hause AM; Baggs J; Marquez P; Abara WE; Olubajo B; Myers TR; Su JR; Thompson D; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):347-351. PubMed ID: 35239637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
    Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
    Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
    Moro PL; Olson CK; Clark E; Marquez P; Strid P; Ellington S; Zhang B; Mba-Jonas A; Alimchandani M; Cragan J; Moore C
    Vaccine; 2022 May; 40(24):3389-3394. PubMed ID: 35489985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
    Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK
    JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
    Hause AM; Baggs J; Marquez P; Myers TR; Gee J; Su JR; Zhang B; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1755-1760. PubMed ID: 34968370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office.
    Miller ER; Moro PL; Shimabukuro TT; Carlock G; Davis SN; Freeborn EM; Roberts AL; Gee J; Taylor AW; Gallego R; Suragh T; Su JR
    Vaccine; 2023 Jun; 41(27):3960-3963. PubMed ID: 37248099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020-January, 2022: an observational cohort study.
    Wong KK; Heilig CM; Hause A; Myers TR; Olson CK; Gee J; Marquez P; Strid P; Shay DK
    Lancet Digit Health; 2022 Sep; 4(9):e667-e675. PubMed ID: 35961858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cohort event monitoring for safety signal detection in adult individuals 18 years and above after immunisation with coronavirus disease 2019 vaccines in Nigeria.
    Osibogun AO; Shuaib FM; Adeyeye CM; Onajole AT; Ejembi CL; Banwat ME; Wright KO; Mohammed A; Adeleye OA; Yahya SJ; Ifeadike CO; Elemuwa UU; Bassey BE; Oluwole EO; Erinoso OA
    Niger Postgrad Med J; 2023; 30(1):18-24. PubMed ID: 36814159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
    Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
    Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women.
    Blakeway H; Amin-Chowdhury Z; Prasad S; Kalafat E; Ismail M; Abdallah FN; Rezvani A; Amirthalingam G; Brown K; Le Doare K; Heath PT; Ladhani SN; Khalil A
    Ultrasound Obstet Gynecol; 2022 Nov; 60(5):673-680. PubMed ID: 36318630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021.
    Razzaghi H; Meghani M; Pingali C; Crane B; Naleway A; Weintraub E; Kenigsberg TA; Lamias MJ; Irving SA; Kauffman TL; Vesco KK; Daley MF; DeSilva M; Donahue J; Getahun D; Glenn S; Hambidge SJ; Jackson L; Lipkind HS; Nelson J; Zerbo O; Oduyebo T; Singleton JA; Patel SA
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(24):895-899. PubMed ID: 34138834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
    Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
    JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.
    Grohskopf LA; Alyanak E; Broder KR; Blanton LH; Fry AM; Jernigan DB; Atmar RL
    MMWR Recomm Rep; 2020 Aug; 69(8):1-24. PubMed ID: 32820746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic.
    Markowitz LE; Hopkins RH; Broder KR; Lee GM; Edwards KM; Daley MF; Jackson LA; Nelson JC; Riley LE; McNally VV; Schechter R; Whitley-Williams PN; Cunningham F; Clark M; Ryan M; Farizo KM; Wong HL; Kelman J; Beresnev T; Marshall V; Shay DK; Gee J; Woo J; McNeil MM; Su JR; Shimabukuro TT; Wharton M; Keipp Talbot H
    Vaccine; 2024 Feb; ():. PubMed ID: 38341293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.